000 | 01932 a2200565 4500 | ||
---|---|---|---|
005 | 20250515202246.0 | ||
264 | 0 | _c20100709 | |
008 | 201007s 0 0 eng d | ||
022 | _a1473-5687 | ||
024 | 7 |
_a10.1097/MEG.0b013e3283353df8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLowette, Klaartje F | |
245 | 0 | 0 |
_aWilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine. _h[electronic resource] |
260 |
_bEuropean journal of gastroenterology & hepatology _cMay 2010 |
||
300 |
_a564-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xcomplications |
650 | 0 | 4 |
_aChelating Agents _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHepatolenticular Degeneration _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Diseases _xdrug therapy |
650 | 0 | 4 |
_aLiver Neoplasms _xcomplications |
650 | 0 | 4 | _aLiver Transplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNervous System Diseases _xdrug therapy |
650 | 0 | 4 | _aPatient Compliance |
650 | 0 | 4 |
_aPenicillamine _xadministration & dosage |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aDesmet, Koen | |
700 | 1 | _aWitters, Peter | |
700 | 1 | _aLaleman, Wim | |
700 | 1 | _aVerslype, Chris | |
700 | 1 | _aNevens, Frederik | |
700 | 1 | _aFevery, Johan | |
700 | 1 | _aCassiman, David M | |
773 | 0 |
_tEuropean journal of gastroenterology & hepatology _gvol. 22 _gno. 5 _gp. 564-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/MEG.0b013e3283353df8 _zAvailable from publisher's website |
999 |
_c19422562 _d19422562 |